The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Canarys Automations Ltd Thrives with ‘Embrace Shift-Left Security’ Event
PUNE, India, July 15, 2024 — Following the resounding success of its event in Mumbai, Canarys Automations Limited (NSE: CANARYS),…
Vestian: 65% of office space in India is green-certified
Delhi, 16th July 2024: Accessing any real estate company’s performance based on ESG becomes crucial as the real estate sector is the…
Crypto Taxation platform TaxNodes Raises $1.6 Mn in Seed Fund Amidst Funding Winter
Bangalore, 15th June 2023 – TaxNodes, a crypto tax computation and expert-assisted ITR filing platform, today announced the successful completion…
